BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 24434384)

  • 21. Evaluation of plasma concentrations of homocysteine, IL-6, TNF-alpha, hs-CRP, and total antioxidant capacity in patients with end-stage renal failure.
    Babaei M; Dashti N; Lamei N; Abdi K; Nazari F; Abbasian S; Gerayeshnejad S
    Acta Med Iran; 2014; 52(12):893-8. PubMed ID: 25530051
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma cytokine levels predict mortality in patients with acute renal failure.
    Simmons EM; Himmelfarb J; Sezer MT; Chertow GM; Mehta RL; Paganini EP; Soroko S; Freedman S; Becker K; Spratt D; Shyr Y; Ikizler TA;
    Kidney Int; 2004 Apr; 65(4):1357-65. PubMed ID: 15086475
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IL-18 is involved in vascular injury in end-stage renal disease patients.
    Porazko T; Kúzniar J; Kusztal M; Kúzniar TJ; Weyde W; Kuriata-Kordek M; Klinger M
    Nephrol Dial Transplant; 2009 Feb; 24(2):589-96. PubMed ID: 18775894
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inflammatory cytokines and malnutrition as related to risk for cardiovascular disease in hemodialysis patients.
    Perunicic-Pekovic G; Pljesa S; Rasic-Milutinovic Z; Stankovic S; Ilic M; Maletic R
    Can J Physiol Pharmacol; 2008 Apr; 86(4):205-9. PubMed ID: 18418430
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel PAradigm to improve Inflammatory burden in end stage Renal disease (rePAIR): study protocol for a randomized controlled trial.
    Trivedi R; Fares G; Nunez VB; Campbell R; Clement M; Burleson J; Himmelfarb J; Ioannidou E
    Trials; 2018 Jul; 19(1):370. PubMed ID: 29996883
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of atorvastatin on lipid profile and non-traditional cardiovascular risk factors in diabetic patients on hemodialysis.
    Navarro JF; Mora C; Muros M; García-Idoate G
    Nephron Clin Pract; 2003; 95(4):c128-35. PubMed ID: 14694274
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Study of the Effects of N-acetylcysteine on Inflammatory Biomarkers and Disease Activity Score in Patients with Rheumatoid Arthritis.
    Jamali F; Ahmadzadeh A; Sahraei Z; Salamzadeh J
    Iran J Allergy Asthma Immunol; 2021 Sep; 20(5):574-583. PubMed ID: 34664816
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comorbidity and acute clinical events as determinants of C-reactive protein variation in hemodialysis patients: implications for patient survival.
    Snaedal S; Heimbürger O; Qureshi AR; Danielsson A; Wikström B; Fellström B; Fehrman-Ekholm I; Carrero JJ; Alvestrand A; Stenvinkel P; Bárány P
    Am J Kidney Dis; 2009 Jun; 53(6):1024-33. PubMed ID: 19394732
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Significance of albumin and C-reactive protein variations in 300 end stage renal disease patients in Tehran University of Medical Sciences Hospitals during year 2010.
    Dashti N; Einollahi N; Nabatchian F; Moradi Sarabi M; Zarebavani M
    Acta Med Iran; 2012; 50(3):197-202. PubMed ID: 22418989
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of adjunctive N-acetylcysteine on depressive symptoms: Modulation by baseline high-sensitivity C-reactive protein.
    Porcu M; Urbano MR; Verri WA; Barbosa DS; Baracat M; Vargas HO; Machado RCBR; Pescim RR; Nunes SOV
    Psychiatry Res; 2018 May; 263():268-274. PubMed ID: 29605103
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effectiveness of N-acetylcysteine for preserving residual renal function in patients undergoing maintenance hemodialysis: multicenter randomized clinical trial.
    Ahmadi F; Abbaszadeh M; Razeghi E; Maziar S; Khoidaki SD; Najafi MT; Lessan-Pezeshki M
    Clin Exp Nephrol; 2017 Apr; 21(2):342-349. PubMed ID: 27206513
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Can serum NGAL levels be used as an inflammation marker on hemodialysis patients with permanent catheter?
    Yigit IP; Celiker H; Dogukan A; Ilhan N; Gurel A; Ulu R; Aygen B
    Ren Fail; 2015 Feb; 37(1):77-82. PubMed ID: 25347233
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vascular access versus the effect of statins on inflammation and fibrinolysis in renal dialysis patients.
    do Sameiro Faria M; Ribeiro S; Rocha-Pereira P; Miranda V; Quintanilha A; Reis F; Costa E; Belo L; Santos-Silva A
    J Vasc Access; 2013; 14(4):335-41. PubMed ID: 23661140
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Short-term effects of an anti-inflammatory treatment on clinical parameters and serum levels of C-reactive protein and proinflammatory cytokines in subjects with periodontitis.
    Renvert S; Lindahl C; Roos-Jansåker AM; Lessem J
    J Periodontol; 2009 Jun; 80(6):892-900. PubMed ID: 19485818
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oxidative stress in hemodialysis patients receiving intravenous iron therapy and the role of N-acetylcysteine in preventing oxidative stress.
    Swarnalatha G; Ram R; Neela P; Naidu MU; Dakshina Murty KV
    Saudi J Kidney Dis Transpl; 2010 Sep; 21(5):852-8. PubMed ID: 20814119
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association between inflammatory mediators and muscle mass in long-term hemodialysis patients.
    Kaizu Y; Ohkawa S; Odamaki M; Ikegaya N; Hibi I; Miyaji K; Kumagai H
    Am J Kidney Dis; 2003 Aug; 42(2):295-302. PubMed ID: 12900811
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Atherosclerosis in hemodialysis patients--the role of microinflammation.
    Bevc S; Sabic S; Hojs R
    Ren Fail; 2008; 30(10):1012-6. PubMed ID: 19016154
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Long term effect of autoadjusting positive airway pressure on C-reactive protein and interleukin-6 in men with obstructive sleep apnoea syndrome].
    Drummond M; Winck J; Guimarães J; Santos AC; Almeida J; Marques J
    Arch Bronconeumol; 2009 Dec; 45(12):577-84. PubMed ID: 19552994
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The impact of dialysis type on biomarkers for cardiovascular diseases.
    Sahinarslan A; Güz G; Mutluay R; Okyay K; Demirtaş C; Paşaoğlu H; Yalçın R
    Turk Kardiyol Dern Ars; 2011 Sep; 39(6):456-62. PubMed ID: 21918314
    [TBL] [Abstract][Full Text] [Related]  

  • 40. How does short-term low-dose simvastatin influence serum prohepcidin levels in patients with end-stage renal disease? A pilot study.
    Li XY; Chang JP; Su ZW; Li JH; Peng BS; Zhu SL; Cai AJ; Zhang J; Jiang Y
    Ther Apher Dial; 2010 Jun; 14(3):308-14. PubMed ID: 20609184
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.